Basic Information
LncRNA/CircRNA Name | MALAT1 |
Synonyms | NA |
Region | GRCh38_11:65497688-65506516 |
Ensemble | ENSG00000251562 |
Refseq | NR_002819 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | breast cancer |
ICD-0-3 | C50 |
Methods | qPCR , Western blot , Northern Blot , RIP etc. |
Sample | The non-tumorigenic, immortalized mammary cell line MCF10A ??reast cancer cell lines(BT474, MCF7, MDAMB-231,MDA-MB-453, SKBR3, and T47D) |
Expression Pattern | up-regulated |
Function Description | Hypoxia induces cancer cell-specific chromatin-chromatin interactions between newly identified enhancer-like cis-regulatory elements present at the MALAT1 locus.Hypoxia-mediated up-regulation of MALAT1 as well as its antisense strand TALAM1 occurs in breast cancer cells..Our analyses on the MALAT1 genomic locus discovered three novel putative enhancers that are located upstream and downstream of the MALAT1 gene body. |
Pubmed ID | 31167784 |
Year | 2019 |
Title | Hypoxia Induces Cancer Cell-Specific Chromatin Interactions and Increases MALAT1 Expression in Breast Cancer Cells |
External Links
Links for MALAT1 | GenBank HGNC NONCODE |
Links for breast cancer | OMIM COSMIC |